Skip to main content
. 2012 Feb 27;11(7):M111.014738. doi: 10.1074/mcp.M111.014738

Table II. Protein overlaps between virus-host interactomes. A. Protein overlaps between full data sets. Overlaps are given as percentages of the number of human proteins targeted by DENV (column 3), EBV (column 4), FLUAV (column 5), HCV (column 6), or VACV (column 7). Stars indicate the level of significance as assessed by random simulation: *: < 5.10−2, **: < 10−3, ***: < 10−4. B. Protein overlaps between full data sets and data sets containing human proteins targeted by at least two proteins of the same virus. Overlaps are given as percentages of the number of human proteins targeted by at least two proteins of DENV (column 3), EBV (column 4), FLUAV (column 5), HCV (column 6), or VACV (column 7). Stars indicate the level of significance as assessed by the hypergeometric distribution: *: < 5.10−2, **: < 10−3, ***: < 10−4.

A % Human proteins targeted by
DENV EBV FLUAV HCV VACV
Human proteins targeted by DENV 100 4.2 (***) 7.0 (***) 6.5 (***) 4.7 (***)
EBV 7.4 (***) 100 13.5 (***) 14.6 (***) 7.0 (***)
FLUAV 5.8 (***) 6.3 (***) 100 5.5 (***) 4.7 (***)
HCV 14.4 (***) 18.4 (***) 14.7 (***) 100 11.7 (***)
VACV 5.3 (***) 4.5 (***) 6.4 (***) 6.0 (***) 100
B % Human proteins targeted by at least two proteins of
DENV EBV FLUAV HCV VACV
Human proteins targeted by DENV 100 8.5 8.8 15.8 (*) 14.3
EBV 17.6 (*) 100 17.6 47.4 (***) 14.3
FLUAV 5.9 14.9 (*) 100 7.9 21.4 (*)
HCV 23.5 44.7 (***) 14.7 100 28.6
VACV 11.8 2.1 5.9 7.9 100
HHS Vulnerability Disclosure